On March 15, 2026, BGI Group initiated a national key R&D program focused on developing convenient, long-read sequencing systems for pathogen detection. This project, part of a national science and technology initiative, involves nine leading domestic institutions. The goal is to accelerate the application of nanopore sequencing technology in diagnosing infectious diseases and responding to public health emergencies.
This national-level project signifies BGI Genomics' leadership in genomic technology for public health. Successful development and deployment of this technology can significantly enhance China's capacity for rapid and accurate diagnosis of infectious diseases, improving pandemic preparedness and response, and potentially creating new market opportunities for BGI's sequencing solutions.
BGI Group is leading a national project on nanopore sequencing for pathogen detection.
The project aims to develop convenient, long-read sequencing systems.
This initiative will accelerate the application of genomic technology in infectious disease control.
This project is a national initiative in China, highlighting the government's investment in advanced diagnostics and BGI's role in bolstering the country's biosecurity and public health infrastructure.
This initiative will accelerate the application of genomic technology in infectious disease control.
BGI Group is leading a national project on nanopore sequencing for pathogen detection.
Sign in to save notes on signals.
Sign In